When Alzheimer's is LATE: Why Does it Matter?

Peter T. Nelson, Julie A. Schneider, Gregory A. Jicha, Michael Tran Duong, David A. Wolk

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

Recent therapeutic advances provide heightened motivation for accurate diagnosis of the underlying biologic causes of dementia. This review focuses on the importance of clinical recognition of limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE affects approximately one-quarter of older adults and produces an amnestic syndrome that is commonly mistaken for Alzheimer's disease (AD). Although AD and LATE often co-occur in the same patients, these diseases differ in the protein aggregates driving neuropathology (Aβ amyloid/tau vs TDP-43). This review discusses signs and symptoms, relevant diagnostic testing, and potential treatment implications for LATE that may be helpful for physicians, patients, and families. ANN NEUROL 2023;94:211–222.

Original languageEnglish
Pages (from-to)211-222
Number of pages12
JournalAnnals of Neurology
Volume94
Issue number2
DOIs
StatePublished - Aug 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'When Alzheimer's is LATE: Why Does it Matter?'. Together they form a unique fingerprint.

Cite this